Ann: Notice of Annual General Meeting/Proxy Form, page-37

It’s ok when they whinge about management …. apparently ? lol

Well at least we are guaranteed an announcement today - the Quarterly …. I will be watching out for the SPL7013 revenues …. JF & Co. will likely incorporate the Mundipharma $6.5 million fee into the SPL7013 revenue total attempting to make them sound a lot better than they are in reality ?

Still no DEP Docetaxel phase 2 readouts and yet this was the first trial to officially finish ? …. first trial to finish but last to readout … seems strange but hey some on here want you to believe that the blame lies with the third party vendors ?

GLTAH but I wouldn’t get your hopes up about the Quarterly as it is likely to be the old cut and paste rhetoric implying how wonderful Starpharma supposedly is with a few DEP highlights rehashing the recent ASX DEP announcements …. IMO if they had anything noteworthy to present in the Quarterly we would have got it earlier rather than leave it to the last possible day ?